Google axed release of vast x-ray dataset following NIH privacy concerns

In 2017, Google was set to publish a dataset containing 100,000 chest x-rays. Two days before that happened, however, the National Institutes of Health phoned the tech-giant explaining those images, which it had provided previously, contained personal patient information; Google then cancelled the release.

The narrowly averted legal catastrophe was reported in a Nov. 15 story published by the Washington Post, which spoke with an anonymous source and reviewed emails on the matter. Those emails revealed that employees at Google worked with the NIH to deidentify personal information from the images, but dates and even jewelry that could potentially identify someone were not properly erased.

Google’s near error highlights the many  potential pitfalls stemming from big tech’s growing obsession with collecting data to revolutionize healthcare.  

“We take great care to protect patient data and ensure that personal information remains private and secure,” Google spokesman Michael Moeschler told the Post. “Out of an abundance of caution, and in the interest of protecting personal privacy, we elected to not host the NIH dataset. We deleted all images from our internal systems and did not pursue further work with NIH.”

Read the entire story below:

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.